Ultragenyx Pharmaceutical
RARE • NASDAQ • Stock Fundamentals
Ultragenyx Pharmaceutical is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Emil D. Kakkis, with a market cap of $2.4B.
Market Cap$2.4B
Employees1.3K
CEOEmil D. Kakkis
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 5, 2026 · 1 month 9 days agoQ1 2026
View reportNext EarningsAug 4, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
Ultragenyx Pharmaceutical FAQ
Common questions about Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical (RARE) has a market capitalization of $2.4B and trades on NASDAQ.
Ultragenyx Pharmaceutical has approximately 1,276 employees.